title: The successful use of repeated courses of OKT3 for hepatic allograft rejection using %T3 cells to adjust dose.
authors.affiliation: Department of Surgery, UCLA School of Medicine, Los Angeles 90024.
authors.forename: J O
authors.initials: JO
authors.lastname: Colonna
authors.forename: J M
authors.initials: JM
authors.lastname: Millis
authors.forename: J
authors.initials: J
authors.lastname: Martello
authors.forename: P
authors.initials: P
authors.lastname: Levy
authors.forename: Y
authors.initials: Y
authors.lastname: Iwaki
authors.forename: J J
authors.initials: JJ
authors.lastname: Brems
authors.forename: A S
authors.initials: AS
authors.lastname: Klein
authors.forename: J R
authors.initials: JR
authors.lastname: Hiatt
authors.forename: R W
authors.initials: RW
authors.lastname: Busuttil
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis*; D017252:CD3 Complex; D004334:Drug Administration Schedule; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation; D011948:Receptors, Antigen, T-Cell / Q000032:analysis*; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D011948:Receptors, Antigen, T-Cell